Autoantibodies in Type 2 Diabetes Patients with Left Ventricular Dilatation: Biomarkers and/or Risk Markers?

Publisher： Karger

E-ISSN： 1421-9751|129|3|189-190

ISSN： 0008-6312

Source： Cardiology, Vol.129, Iss.3, 2014-10, pp. : 189-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Autoantibodies against β1 Receptor and AT1 Receptor in Type 2 Diabetes Patients with Left Ventricular Dilatation

By  

Cardiology, Vol. 129, Iss. 3, 2014-10 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 1, 2015-02 ,pp. : 39-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adiponectin Is Associated with Brain Natriuretic Peptide and Left Ventricular Hypertrophy in Hemodialysis Patients with Type 2 Diabetes Mellitus

By  

Nephron Clin Pract, Vol. 107, Iss. 3, 2007-09 ,pp. : c103-c108

Karger

Access to resources Recommend Favorite

The effects of good glycaemic control on left ventricular and coronary endothelial functions in patients with poorly controlled Type 2 diabetes mellitus

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 388-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Left Ventricular Mechanics in Untreated Normotensive Patients with Type 2 Diabetes Mellitus: A Two‐ and Three‐dimensional Speckle Tracking Study

By  

ECHOCARDIOGRAPHY (ELECTRONIC), Vol. 32, Iss. 6, 2015-06 ,pp. : 947-955

John Wiley & Sons Inc

Access to resources Recommend Favorite